T cell repleteâhaploidentical second hematopoietic stem cell transplantation for primary graft failure in pediatric patients with hematologic malignancies
Pediatric Transplantation Aug 31, 2017
Mochizuki K, et al. – The efficacy of T cell replete (TCR)–haploidentical second hematopoietic stem cell transplantation (HSCT) was examined for primary graft failure (GF) in children with hematologic malignancies. Outcomes supported that TCR–haploidentical second HSCT was feasible for pediatric patients. Moreover, this approach might provide a potent option for children with primary GF.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
